Kathmere Capital Management, LLC Oragenics Inc Transaction History

Kathmere Capital Management, LLC

  • $1.02 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 07, 2021
SELL
$0.52 - $1.52 $13 - $38
-25 Closed
0 $0
Q3 2020

Nov 20, 2020
BUY
$0.56 - $1.49 $14 - $37
25 New
25 $0

Others Institutions Holding OGEN

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About ORAGENICS INC

OGEN Quotes by TradingView
  • Ticker OGEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 116,395,000
  • Market Cap $40.7M
  • Description
  • Oragenics, Inc. develops antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus; and Terra CoV-2, an intramuscular vaccine candidate that provides immuni...
More about OGEN
Track This Portfolio

Track Kathmere Capital Management, LLC Portfolio

Follow Kathmere Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kathmere Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kathmere Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email